Ultrasound enhancement of percutaneous drug absorption
US7004933B2 · kind B2 · utility
68Cited by
35References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 8, 2001 |
| Grant date | Feb 28, 2006 |
| Priority date | — |
| Expiry date | Jun 29, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2037/0007
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A system for enhancing and improving the transcutaneous or transdermal delivery of topical chemicals or drugs. A disposable container contains a substantially sterile unit dose of an active agent adapted for a single use in a medical treatment. The unit dose is formulated to enhance transport of the active agent through mammalian skin when the active agent is applied to the skin and the skin is exposed to light and/or ultrasound defined by at least one specific parameter.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.